Advances in the etiology and treatment of non-obese nonalcoholic fatty liver disease
DOI:10.3969/j.issn.1001-5256.2021.02.043
- VernacularTitle:非肥胖型非酒精性脂肪性肝病的病因及治疗进展
- Author:
Yangyang LI
1
;
Zhengyuan XIE
Author Information
1. Department of Gastroenterology, The Second Affiliated Hospital of Nanchang University, Nanchang 330006, China
- Publication Type:Research Article
- Keywords:
Non-alcoholic Fatty Liver Disease;
Risk Factors;
Therapeutics;
Prognosis
- From:
Journal of Clinical Hepatology
2021;37(2):452-457
- CountryChina
- Language:Chinese
-
Abstract:
With the prevalence of nonalcoholic fatty liver disease (NAFLD) in the non-obese population, more and more studies have explored the significance of NAFLD in such population. Compared with the patients with obese NAFLD, the patients with non-obese NAFLD lack the phenotype of obesity, but they still have metabolic disorders and higher risk of metabolic and cardiovascular diseases. At present, there are no effective drugs for the treatment of non-obese NAFLD, and the existing treatment methods have their own advantages and limitations in clinical practice. This article reviews the advances in the etiology and treatment of non-obese NAFLD, in order to provide a reference for guiding the clinical treatment of non-obese NAFLD.
